Instrument Inactif

Autres langues Cyclacel Pharmaceuticals Inc Nasdaq

Actions

US23254L1089

Recherche biotechnologique et médicale

Cours en clôture Nasdaq
- ^USD	-

12/08	Bio Green Med Solution, Inc. publie ses résultats pour le deuxième trimestre clos le 30 juin 2026	CI
05/06	Bio Green Med Solution, Inc. et Future Nrg Sdn Bhd annoncent des changements au sein de leur conseil d'administration	CI

Autres langues

12/08	BIO GREEN MED SOLUTION REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
12/08	Bio Green Med Solution, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2026
05/06	Bio Green Med Solution, Inc. and Future Nrg Sdn Bhd Announces Board Changes
05/06	BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD.
05/06	Top Premarket Gainers
04/06	Bio Green Med Solution Enters Business Combination Agreement to Acquire Future NRG
04/06	BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD.
04/06	Future NRG Sdn Bhd entered into a Business Combination Agreement to acquire Bio Green Med Solution, Inc. in a reverse merger transaction for $2.0 billion.
14/05	BIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
14/05	Bio Green Med Solution, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
30/03	BIO GREEN MED SOLUTION REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
30/03	Bio Green Med Solution, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
30/03	Bio Green Med Solution, Inc. Auditor Raises 'Going Concern' Doubt
17/02	Mainz Biomed N.V. Appoints David E. Lazar as Temporary Non-Executive Director and Chair of the Board, Effective February 13, 2026
13/11	Bio Green Med Solution, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
13/11	Bio Green Med Solution Reports Third Quarter Financial Results and Provides Business Update
07/10/25	Bio Green Med Solution, Inc. acquired Assets and Rights of Plogosertib from Tethra Biosciences Inc. for $0.47 million.
25/09/25	Bio Green Med Solution, Inc. Announces Board and Committee Changes
15/09/25	Fitters Diversified Closes Sale of Unit in a Stock Deal; Shares Rally 20%
12/09/25	Bio Green Med Solution announces closing of strategic acquisition of Fitters Sdn. Bhd.
12/09/25	Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd.
12/09/25	Cyclacel Pharmaceuticals, Inc. completed the acquisition of Fitters Sdn Bhd from FITTERS Diversified Berhad for $4.5 million.
02/09/25	Cyclacel Pharmaceuticals : Initial Statement of Beneficial Ownership (Form 3)
02/09/25	Cyclacel Pharmaceuticals : Initial Statement of Beneficial Ownership (Form 3)
02/09/25	Cyclacel Pharmaceuticals : Initial Statement of Beneficial Ownership (Form 3)